The Global Pain Management Devices Market surged to USD 3.7 billion in 2022 and is poised for substantial growth, projected to reach USD 6.3 billion by 2031, with a projected Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period from 2024 to 2031.
Pain management devices encompass a range of medical devices extensively utilized for managing various forms of pain, including neuropathic pain, cancer pain, nociceptive pain, and musculoskeletal pain, among others. Among the pain management devices prevalent in the market are electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices.
Several factors contribute to the significant growth of the global pain management devices market. Escalating technological advancements and substantial research and development efforts in pain management play a crucial role in expanding the market. Additionally, there is an increasing demand for point-of-care testing, and the recurrence of pain after surgery further drives market growth.
Overall, the growth trajectory of the global pain management devices market is fueled by a convergence of factors, highlighting the importance of innovative solutions in addressing the diverse needs of patients experiencing various forms of pain.
-
Stimulated Neuromodulator Devices
-
Transcutaneous Electrical Nerve Stimulation (TENS) Devices
-
Spinal Cord Stimulation (SCS) Devices
-
Ablation Devices
-
Cryoablation Devices
-
Cancer Pain
-
Musculoskeletal Pain
-
Migraine
-
Neuropathic Pain
-
Others
Major players are Stim Wave LLC, Baxter International, Inc., Boston Scientific Corp., ICU Medical Inc, Johnson & Johnson Company, DJO Global LLC, Liva Nova., Medtronic Plc, Smiths Medical, Abbott, and Stryker Corp.
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian